LAVAL, Quebec, Oct. 17, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release third quarter 2016 financial results on Tuesday, November 8, 2016, prior to the conference call and live webcast at 8:00 a.m. ET, when the Company will discuss the results.
Conference Call Details
Tuesday, November 8, 2016
8:00 a.m. ET
Participant Event Dial-in
(877) 876-8393 (North America)
(973) 200-3961 (International)
(855) 859-2056 (North America)
(404) 537-3406 (International)
49468113 (replay available until November 16, 2016)
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
877-281-6642 (toll free)
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-announces-third-quarter-financial-results-date-and-conference-call-details-300345912.html
SOURCE Valeant Pharmaceuticals International, Inc.